These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Degradation of basement membrane by prostate tumor heparanase. Kosir MA, Wang W, Zukowski KL, Tromp G, Barber J. J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056 [Abstract] [Full Text] [Related]
3. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin. Bitan M, Mohsen M, Levi E, Wygoda MR, Miao HQ, Lider O, Svahn CM, Ekre HP, Ishai-Michaeli R, Bar-Shavit R. Isr J Med Sci; 1995 Jan; 31(2-3):106-18. PubMed ID: 7744578 [Abstract] [Full Text] [Related]
4. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells. Savion N, Disatnik MH, Nevo Z. J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131 [Abstract] [Full Text] [Related]
5. Evidence that platelet and tumour heparanases are similar enzymes. Freeman C, Browne AM, Parish CR. Biochem J; 1999 Sep 01; 342 ( Pt 2)(Pt 2):361-8. PubMed ID: 10455023 [Abstract] [Full Text] [Related]
6. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis. Xu X, Quiros RM, Maxhimer JB, Jiang P, Marcinek R, Ain KB, Platt JL, Shen J, Gattuso P, Prinz RA. Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5968-79. PubMed ID: 14676122 [Abstract] [Full Text] [Related]
7. Sorting of heparan sulfate proteoglycan into matrix compartments of prostate adenocarcinoma cells. Kosir MA, Quinn CC. J Surg Res; 1995 Jan 01; 58(1):46-52. PubMed ID: 7830405 [Abstract] [Full Text] [Related]
11. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix. Bar-Ner M, Mayer M, Schirrmacher V, Vlodavsky I. J Cell Physiol; 1986 Aug 01; 128(2):299-306. PubMed ID: 2426287 [Abstract] [Full Text] [Related]
12. Mammalian heparanase as mediator of tumor metastasis and angiogenesis. Vlodavsky I, Elkin M, Pappo O, Aingorn H, Atzmon R, Ishai-Michaeli R, Aviv A, Pecker I, Friedmann Y. Isr Med Assoc J; 2000 Jul 01; 2 Suppl():37-45. PubMed ID: 10909416 [Abstract] [Full Text] [Related]
13. Involvement of human heparanase in the pathogenesis of diabetic nephropathy. Katz A, Van-Dijk DJ, Aingorn H, Erman A, Davies M, Darmon D, Hurvitz H, Vlodavsky I. Isr Med Assoc J; 2002 Nov 01; 4(11):996-1002. PubMed ID: 12489489 [Abstract] [Full Text] [Related]
14. Function of heparanase in prostate tumorigenesis: potential for therapy. Lerner I, Baraz L, Pikarsky E, Meirovitz A, Edovitsky E, Peretz T, Vlodavsky I, Elkin M. Clin Cancer Res; 2008 Feb 01; 14(3):668-76. PubMed ID: 18212251 [Abstract] [Full Text] [Related]
15. Lung colonization by and heparanase activity in in vitro transformed 3T3 cells rendered highly tumorigenic by an in vivo passage. Katz BZ, Ishai-Michaeli R, Zusman T, Vlodavsky I, Witz IP. Invasion Metastasis; 2008 Feb 01; 14(1-6):276-89. PubMed ID: 7657521 [Abstract] [Full Text] [Related]